No CrossRef data available.
Article contents
Development of systemic-to-pulmonary collateral arteries in a patient with hypoplastic left cardiac syndrome after bilateral pulmonary artery banding
Published online by Cambridge University Press: 29 April 2010
Abstract
We describe systemic-to-pulmonary collateral arteries that developed after bilateral pulmonary artery banding in a patient with hypoplastic left cardiac syndrome. The growth of collateral arteries should be evaluated carefully because bilateral pulmonary artery banding under prostaglandin E1 administration is considered an initial palliative option.
- Type
- Brief Reports
- Information
- Copyright
- Copyright © Cambridge University Press 2010
References
1. Ohye, RG, Devaney, EJ, Hirsch, JC, Bove, EL. The modified Blalock–Taussig shunt versus the right ventricle-to-pulmonary artery conduit for the Norwood procedure. Pediatr Cardiol 2007; 28: 122–125.CrossRefGoogle ScholarPubMed
2. Takabayashi, S, Shimpo, H, Kajimoto, M, Yokoyama, K, Kado, H, Mitani, Y. Stage I bilateral pulmonary artery banding maintains systemic flow by prostaglandin E1 infusion or a main pulmonary artery to the descending aorta shunt for hypoplastic left heart syndrome. Interact Cardiovasc Thorac Surg 2005; 4: 352–355.CrossRefGoogle Scholar
3. Takabayashi, S, Shimpo, H, Ozu, Y, Yokoyama, K, Kajimoto, M. A Fontan completion through stage I bilateral pulmonary artery banding for hypoplastic left heart syndrome. J Throrac Cardiovasc Surg 2005; 130: 1464–1465.CrossRefGoogle Scholar
4. Akinturk, H, Michel-Behnke, I, Valeske, K, et al. . Hybrid transcatheter-surgical palliation. Pediatr Cardiol 2007; 28: 79–87.CrossRefGoogle ScholarPubMed
5. Nakanishi, T. Cardiac catheterization is necessary before bidirectional Glenn and Fontan procedures in single ventricle physiology. Pediatr Cardiol 2005; 26: 159–161.CrossRefGoogle ScholarPubMed
6. Haider, DG, Bucek, RA, Giurgea, AG, et al. . PGE1 analog alprostadil induces VEGF and eNOS expression in endothelial cells. Am J Physiol Heart Circ Physiol 2005; 289: 2066–2072.CrossRefGoogle ScholarPubMed
7. Mehrabi, MR, Serbecic, N, Tamaddon, F, et al. . Clinical and experimental evidence of prostaglandin E1-induced angiogenesis in the myocardium of patients with ischemic heart disease. Cardiovasc Res 2002; 56: 214–224.CrossRefGoogle ScholarPubMed
8. Makino, H, Aoki, M, Hashiya, N, et al. . Increase in peripheral blood flow by intravenous administration of prostaglandin E1 in patients with peripheral arterial disease, accompanied by up-regulation of hepatocyte growth factor. Hypertens Res 2004; 27: 85–91.CrossRefGoogle ScholarPubMed